Symbol="MRNS"
AssetType="Common Stock"
Name="Marinus Pharmaceuticals Inc"
Description="Marinus Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on developing and commercializing therapies to treat rare seizure disorders. The company is headquartered in Radnor, Pennsylvania."
CIK="1267813"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="170 N RADNOR CHESTER RD, SUITE 250, RADNOR, PA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="358321000"
EBITDA="-119317000"
PERatio="None"
PEGRatio="0"
BookValue="1.133"
DividendPerShare="0"
DividendYield="0"
EPS="-0.19"
RevenuePerShareTTM="0.557"
ProfitMargin="-1.066"
OperatingMarginTTM="-4.765"
ReturnOnAssetsTTM="-0.498"
ReturnOnEquityTTM="-0.891"
RevenueTTM="25963000"
GrossProfitTTM="-55943000"
DilutedEPSTTM="-0.19"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="2.397"
AnalystTargetPrice="20.6"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="10.21"
PriceToBookRatio="2.654"
EVToRevenue="5.83"
EVToEBITDA="-37.38"
Beta="1.29"
num_52WeekHigh="11.15"
num_52WeekLow="3.465"
num_50DayMovingAverage="9.34"
num_200DayMovingAverage="7.17"
SharesOutstanding="50610000"
DividendDate="2020-09-23"
ExDividendDate="None"
symbol="MRNS"
open="7.08"
high="7.36"
low="6.92"
price="7.34"
volume="367971.00"
latest_trading_day="2023-08-28"
previous_close="7.05"
change="0.29"
change_percent="4.1135%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="12"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="88"
Volume_recent_avg="792396"
Change_recent_avg="0.01"
Delta_recent_avg="0.57"
Variance_recent_avg="0.28"
Change_ratio_recent_avg="-0.13"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="88"
Aroon_momentum_negative="12"
image_negative_thumbnail_id_1="1111"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0144.jpeg"
image_negative_thumbnail_id_2="1116"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0149.jpeg"
image_neutral_thumbnail_id_1="544"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0055.jpeg"
image_neutral_thumbnail_id_2="564"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0035.jpeg"
image_positive_thumbnail_id_1="633"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0075.jpeg"
image_positive_thumbnail_id_2="989"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0151.jpeg"
image_professor_thumbnail_id_1="1173"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0007.jpeg"
image_professor_thumbnail_id_2="1188"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0022.jpeg"
